Fingerprint
Dive into the research topics of 'Phase II trial of 150-minute weekly infusion of gemcitabine in advanced colorectal cancer: Minimal activity in colorectal cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase II trial of 150-minute weekly infusion of gemcitabine in advanced colorectal cancer: Minimal activity in colorectal cancer
Sridhar Mani, John W. Kugler, James A. Knost, David F. Sciortino, Joseph Gibbons, Juan C. Garcia, Rafat H. Ansari, Richard L. Schilsky, Everett E. Vokes
Research output: Contribution to journal › Article › peer-review
36
Scopus
citations